INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated – CORT

(NASDAQ:CORT), NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Corcept and certain of its officers and/or directors have […]

Overworld Unveils Real-Time Diffusion World Model for Playable, AI-Native Worlds

Overworld Unveils Real-Time Diffusion World Model for Playable, AI-Native Worlds GlobeNewswire January 20, 2026 PROVIDENCE, R.I., Jan. 20, 2026 (GLOBE NEWSWIRE) — Today, Overworld (formerly Wayfarer Labs) announced the release of a research preview of its local-first diffusion world model. This model is an early, experimental system targeted toward researchers, engineers, and builders. The company

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated – CORT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated – CORT GlobeNewswire January 20, 2026 NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT). Such investors are advised to contact Danielle

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. – ZBIO

(NASDAQ:ZBIO), NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. (“Zenas” or the “Company”) (NASDAQ: ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Zenas and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. – ZBIO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. – ZBIO GlobeNewswire January 20, 2026 NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. (“Zenas” or the “Company”) (NASDAQ: ZBIO). Such investors are advised to contact Danielle

REINCE PRIEBUS JOINS FOX NEWS MEDIA AS POLITICAL ANALYST

FOX News Media has signed Reince Priebus as a political analyst, where he will appear across all platforms. He will make his debut on FOX News Channel’s Hannity (9 PM/ET) this evening with Sean Hannity. Priebus currently serves as President of Michael Best & Friedrich LLP, Chairman of Michael Best Strategies and is a senior

Dream Exchange Market Report: 2025 Data Reveals 50% Decline in Total U.S. Listed Companies Since 1996 Peak; Highlights SPAC Dominance in New Offerings

The report analyzes the composition of the 202 IPOs priced in 2025 and reviews multi-decade trends in market access and capital formation. Dream Exchange, an organization dedicated to creating equal access to capital markets for emerging businesses, today released an analysis of the 2025 Initial Public Offering (IPO) data. The report contrasts current year activity

IDB Bank Appoints David Park as President of Commercial Banking

The Appointment Unifies IDB Bank’s Commercial Banking Platform Nationwide to Support Next Phase of Growth and Transformation. IDB Bank (IDB), a New York-based private and commercial bank, and the largest Israeli-owned bank operating in the United States, today announced the appointment of David Park as President of Commercial Banking, effective January 5, 2026. In this

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apogee Enterprises, Inc. – APOG

(NASDAQ:APOG), NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Apogee Enterprises, Inc. (“Apogee” or the “Company”) (NASDAQ: APOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Apogee and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines – MCTA

(NASDAQ:MCTA), NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Charming Medical Ltd. (“Charming” or the “Company”) (NASDAQ: MCTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

Scroll to Top